Although members of the ERBB family are believed to be involved in cancer progression and have been identified in solid tumors and targeted in certain therapies for cancer treatment, much of their contribution to the progression of CC remains unknown relative to that of other types of tumors. This evidence concerns the gene EGFR and cancer.